STEROID-SPARING EFFECT OF INHALED LYSINE ACETYLSALICYLATE AND FUROSEMIDE IN HIGH-DOSE BECLOMETHASONE-DEPENDENT ASTHMA

被引:17
作者
BIANCO, S
VAGHI, A
ROBUSCHI, M
REFINI, RM
PIERONI, MG
SESTINI, P
机构
[1] UNIV SIENA, INST RESP DIS, I-53100 SIENA, ITALY
[2] UNIV MILAN, OSPED SAN RAFFAELE, INST RESP & CARDIOVASC DIS, I-20127 MILAN, ITALY
[3] UNIV MILAN, INST RESP DIS, MILAN, ITALY
关键词
LYSINE ACETYLSALICYLATE; ASPIRIN; FUROSEMIDE; NONSTEROIDAL ANTIINFLAMMATORY DRUG; BECLOMETHASONE; STEROID-DEPENDENT ASTHMA;
D O I
10.1016/S0091-6749(95)70092-7
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Inhaled lysine acetylsalicylate and furosemide exert a mutually potentiating protective activity on experimentally induced bronchoconstriction in asthma. Objective: Our purpose was to investigate the clinical effectiveness of combined treatment of asthma with inhaled lysine acetylsalicylate and furosemide. Methods: We performed a randomized, double-blind crossover study in nine patients with chronic asthma requiring a high dose (2 mg/day) of inhaled beclomethasone for clinical control. Patients were treated with a combination of 720 mg inhaled lysine acetylsalicylate and 40 mg furosemide twice daily, or with matched placebo in addition to inhaled steroids. The dose of inhaled steroids was reduced by half every 15 days and eventually suspended unless a patient's respiratory condition worsened. Results: During treatment with placebo all patients had worsening of asthma at dosages of I or 0.5 mg/day beclomethasone (mean +/- SE, 833 +/- 83 mu g/day). During combined treatment complete suspension of inhaled steroids in two patients and reduction to 0.5 to 0.25 mg in the remaining seven patients (mean, 250 +/- 72 mu g/day) was achieved, with a mean reduction of 71% +/- 7%. Forced expiratory volume in 1 second weekly peak expiratory flow rate, symptom score, and bronchodilator intake remained significantly better with combined treatment than with placebo. Conclusions: Treatment with inhaled lysine acetylsalicylate and furosemide allows a considerable sparing of inhaled steroids without significant side effects inpatients with severe asthma.
引用
收藏
页码:937 / 943
页数:7
相关论文
共 31 条
  • [1] TRIAL OF CYCLOSPORINE IN CORTICOSTEROID-DEPENDENT CHRONIC SEVERE ASTHMA
    ALEXANDER, AG
    BARNES, NC
    KAY, AB
    [J]. LANCET, 1992, 339 (8789) : 324 - 328
  • [2] [Anonymous], 1990, BRIT MED J, V301, P651
  • [3] BARNES PJ, 1989, NEW ENGL J MED, V321, P1517
  • [4] PROTECTIVE ACTIVITY OF INHALED NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON BRONCHIAL RESPONSIVENESS TO ULTRASONICALLY NEBULIZED WATER
    BIANCO, S
    VAGHI, A
    PIERONI, MG
    ROBUSCHI, M
    REFINI, RM
    SESTINI, P
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 90 (05) : 833 - 839
  • [5] BIANCO S, 1988, LANCET, V2, P252
  • [6] BIANCO S, 1977, IRCS (International Research Communications System) Medical Science Library Compendium, V5, P129
  • [7] POTENTIATION OF THE ANTIREACTIVE, ANTIASTHMATIC EFFECT OF INHALED FUROSEMIDE BY INHALED LYSINE ACETYLSALICYLATE
    BIANCO, S
    VAGHI, A
    PIERONI, MG
    ROBUSCHI, M
    REFINI, RM
    BERNI, F
    SESTINI, P
    [J]. ALLERGY, 1993, 48 (08) : 570 - 575
  • [8] PROTECTIVE EFFECT OF INHALED PIRETANIDE ON THE BRONCHIAL OBSTRUCTIVE RESPONSE TO ULTRASONICALLY NEBULIZED H2O - A DOSE-RESPONSE STUDY
    BIANCO, S
    ROBUSCHI, M
    VAGHI, A
    PIERONI, MG
    SESTINI, P
    [J]. CHEST, 1993, 104 (01) : 185 - 188
  • [9] BIANCO S, 1993, INT CONGR SER, V1007, P261
  • [10] BIANCO S, 1993, EUR RESPIR J, V6, P130